statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	1.066
SG - Singapore	258
CN - Cina	191
IT - Italia	178
PL - Polonia	139
VN - Vietnam	78
BR - Brasile	67
HK - Hong Kong	59
DE - Germania	54
UA - Ucraina	53
GB - Regno Unito	47
FR - Francia	32
TR - Turchia	32
BD - Bangladesh	22
FI - Finlandia	19
JP - Giappone	16
BE - Belgio	14
CA - Canada	14
RU - Federazione Russa	14
AR - Argentina	10
MX - Messico	10
IN - India	9
ID - Indonesia	8
CO - Colombia	7
NL - Olanda	6
UZ - Uzbekistan	6
CH - Svizzera	5
ZA - Sudafrica	5
VE - Venezuela	4
CL - Cile	3
DK - Danimarca	3
EC - Ecuador	3
GE - Georgia	3
KE - Kenya	3
PE - Perù	3
PK - Pakistan	3
SE - Svezia	3
AE - Emirati Arabi Uniti	2
CZ - Repubblica Ceca	2
ET - Etiopia	2
GT - Guatemala	2
IQ - Iraq	2
IR - Iran	2
JM - Giamaica	2
JO - Giordania	2
KW - Kuwait	2
MA - Marocco	2
PH - Filippine	2
PY - Paraguay	2
RW - Ruanda	2
TW - Taiwan	2
UY - Uruguay	2
AL - Albania	1
AM - Armenia	1
AQ - Antartide	1
AT - Austria	1
AU - Australia	1
AZ - Azerbaigian	1
BB - Barbados	1
BG - Bulgaria	1
DZ - Algeria	1
ES - Italia	1
GR - Grecia	1
IL - Israele	1
KG - Kirghizistan	1
KZ - Kazakistan	1
LB - Libano	1
MD - Moldavia	1
NC - Nuova Caledonia	1
OM - Oman	1
PT - Portogallo	1
SA - Arabia Saudita	1
SK - Slovacchia (Repubblica Slovacca)	1
TH - Thailandia	1
Totale	2.499

Nome	#
Molecular mechanisms impairing biosynthesis and function of hemostatic proteins	336
Responsiveness of hemophilia B- causing non sense mutations to ribosome readthrough-inducing drugs strictly depends on the nucleotide and prrotein context	244
Cationic lipid nanosystems as carriers for nucleic acids	237
Nuove strategie per la veicolazione di acidi nucleici: nanosistemi cationici a matrice lipidica	232
Ribosome readthrough accounts for secreted full-length factor IX in hemophilia B patients with nonsense mutations	201
Nanosistemi lipidici per la veicolazione di acidi nucleici	195
Replacement of the Y450 (c234) phenyl ring in the carboxyl-terminal region of coagulation factor IX causes pleiotropic effects on secretion and enzyme activity	180
Long-chain cationic derivatives of PTA (1,3,5-triaza-7-phosphaadamantane) as new components of potential non-viral vectors	177
RNA-based therapeutic approaches for blood coagulation factor deficiencies caused by a splicing mutations	158
Long-chain cationic derivatives of 1,3,5-triaza-7-phosphaadamantane as a tool to obtain new non-viral vectors	124
In vivo modulation of a dominant-negative variant in mouse models of von Willebrand disease type 2A	124
Long-chain cationic derivatives of PTA (1,3,5-triaza-7- phosphaadamantane) based SLN as new potential non-viral vectors	122
RNA−based therapeutic approaches for blood coagulation factor deficiencies caused by splicing mutations	116
null	73
Totale	2.519

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	153	7	20	6	2	6	4	5	23	7	10	11	52
2022/2023	128	15	7	5	7	33	14	11	5	11	0	11	9
2023/2024	99	9	4	6	4	6	13	8	9	2	8	5	25
2024/2025	339	11	7	32	13	37	57	17	7	42	30	46	40
2025/2026	961	85	48	73	121	176	56	115	62	78	77	49	21
2026/2027	17	17	0	0	0	0	0	0	0	0	0	0	0
Totale													2.519

SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara